- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- Show all
- 50th Anniversary
- Abortion
- Affordable Care Act
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Coronavirus
- Cost-sharing
- Court Access
- Data Collection
- Defending Medicaid
- Demonstrations
- Disability Rights
- Doula Care
- Dual Eligible Beneficiaries
- Dually eligible
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- Federal and State Court Cases
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Home and Community Based Services
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medi-Cal
- Medicaid
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Public Charge
- Public Health
- Reproductive Health
- Services
- Supreme Court
- Telehealth
- Waivers and Demonstrations
- Women's Health
- women's health
… results in All United States.
- October 27, 2020
The Congressional Review Act: Frequently Asked Questions
Read moreThe CRA requires executive branch agencies to report their rulemaking activities to Congress and creates a process for Congress…
- October 13, 2020
NHeLP response to HHS Request for Information on Guidance Documents
Read moreHHS posted an undated Request for Information (RFI) on its website asking for input on which guidance documents should…
- September 17, 2020
NHeLP comments on Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”)
Read moreThe Orange Book is an important and informative drug resource for a range of stakeholders. In a request for…
- September 14, 2020
NHeLP comments on HHS Proposed Rule on Guidance
Read moreGuidance documents are a valuable tool that allows agencies to clarify policy issues and explain ambiguities raised by the…
